Biomarkers of Favorable vs. Unfavorable Responses in Locally Advanced Rectal Cancer Patients Receiving Neoadjuvant Concurrent Chemoradiotherapy
Details
The content you want is available to Zendy users.Already have an account? Click here. to sign in.
Details